MARIA GRANT: Open Payments
NPI 1811389844 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 17 payments from 9 companies in 2025. Trend: 2023 $825 · 2024 $538 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $152 |
| AstraZeneca Pharmaceuticals LP | 3 | $149 |
| PFIZER INC. | 3 | $67 |
| ABIOMED | 2 | $64 |
| Novo Nordisk Inc | 2 | $62 |
| Amgen Inc. | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Symbravo, FARXIGA, NURTEC ODT, Ozempic, INSPIRE, REPATHA, OTEZLA, Korlym.
Industry payments across TX — which companies pay providers there.
